Pharmaceutical manufacturing has traditionally been performed using batch process techniques. Batch processes have been proven over many decades of use, but can have shortcomings when it comes to ...
CDMO Cambrex, an early adopter of continuous flow manufacturing, has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina. A growing ...
The antibiotic cefazolin is an essential drug according to the World Health Organization (WHO). It is usually produced via batch manufacturing, but this multistep process is time-consuming, wasteful ...
One of the main challenges came from the complex structure of cefazolin itself. Until now, no one had seemingly been able to develop a reaction method capable of synthesizing a highly purified drug by ...
The antibiotic cefazolin is an essential drug according to the World Health Organization (WHO). It is usually produced via batch manufacturing, but this multistep process is time-consuming, wasteful ...
The main market opportunities lie in enhancing supply chain resilience, reducing production costs and cycle times, and ...
“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...
Although continuous flow chemistry—wherein molecules are made in a continuous process rather than in batches—has gained ground in academic labs, its adoption by industry and contract manufacturing ...
DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...
A photo of technicians working in front of a process train. Novartis's continuous manufacturing center in Basel, Switzerland, replicates an end-to-end manufacturing process developed at the ...
RICHMOND, Va.--(BUSINESS WIRE)--Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a strategic alliance to develop a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results